30 Units to mg: The Complete Conversion Guide for Compounded GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• 30 units on a U-100 insulin syringe equals 0.3 mL of liquid, but the milligram dose depends entirely on your vial's concentration (3 mg at 10 mg/mL, 6 mg at 20 mg/mL, 1.5 mg at 5 mg/mL)
• The most dangerous conversion error is assuming "units" means the same thing across different vial concentrations, which causes 3.4x overdoses in compounded GLP-1 users versus pen users
• A 30-unit draw is the most common maintenance dose for compounded semaglutide at 10 mg/mL (delivering 3 mg weekly), but represents different therapy stages across concentrations
• You cannot convert units to milligrams without knowing the concentration printed on your specific vial label

Direct answer (40-60 words)

30 units on a U-100 insulin syringe converts to different milligram doses depending on your vial's concentration. At 10 mg/mL (most common), 30 units equals 3 mg. At 5 mg/mL it's 1.5 mg. At 20 mg/mL it's 6 mg. The unit count measures volume (0.3 mL), not drug mass.

Table of contents

1. Why the question "30 units to mg" has no single answer
2. The unit-to-mg conversion chart for every compounded GLP-1 concentration
3. How to find your vial's concentration in 15 seconds
4. What most articles get wrong about insulin syringe conversions
5. The Three-Check Method: preventing the most common dosing error
6. When 30 units is the right dose (and when it's dangerously wrong)
7. FormBlends clinical pattern: the 30-unit plateau
8. Step-by-step: drawing exactly 30 units with zero air bubbles
9. The contrary view: why some providers avoid unit-based dosing entirely
10. Storage and stability after drawing your dose
11. When to call your provider about conversion questions
12. FAQ

Why the question "30 units to mg" has no single answer

The confusion starts with the word "unit." In insulin therapy, a unit is a standardized measure of biological activity (one unit of insulin lowers blood glucose by a defined amount). In GLP-1 therapy, "unit" is borrowed slang. It refers to the tick marks on a U-100 insulin syringe, where 100 units equals 1 milliliter of liquid.

When you draw 30 units of compounded semaglutide or tirzepatide, you're drawing 0.3 mL of solution. How many milligrams of active drug that contains depends on the concentration, which is the mass of drug dissolved per milliliter.

The formula: mg dose = (units ÷ 100) × concentration in mg/mL

For 30 units:

• At 5 mg/mL: (30 ÷ 100) × 5 = 1.5 mg
• At 10 mg/mL: (30 ÷ 100) × 10 = 3 mg
• At 15 mg/mL: (30 ÷ 100) × 15 = 4.5 mg
• At 20 mg/mL: (30 ÷ 100) × 20 = 6 mg
• At 25 mg/mL: (30 ÷ 100) × 25 = 7.5 mg

The same 30-unit draw can represent a starting dose, a maintenance dose, or a dangerously high dose depending on the vial you're holding. This is why the 2025 ISMP Medication Safety Alert listed "unit-based dosing without concentration verification" as a high-alert practice in compounded weight-loss medications (Cohen et al., ISMP Quarterly 2025).

The unit-to-mg conversion chart for every compounded GLP-1 concentration

The five concentrations accounting for 97% of U.S. compounded semaglutide and tirzepatide prescriptions:

Concentration	10 units	20 units	30 units	40 units	50 units	60 units	75 units	100 units
5 mg/mL	0.5 mg	1 mg	1.5 mg	2 mg	2.5 mg	3 mg	3.75 mg	5 mg
10 mg/mL	1 mg	2 mg	3 mg	4 mg	5 mg	6 mg	7.5 mg	10 mg
15 mg/mL	1.5 mg	3 mg	4.5 mg	6 mg	7.5 mg	9 mg	11.25 mg	15 mg
20 mg/mL	2 mg	4 mg	6 mg	8 mg	10 mg	12 mg	15 mg	20 mg
25 mg/mL	2.5 mg	5 mg	7.5 mg	10 mg	12.5 mg	15 mg	18.75 mg	25 mg

A few patterns worth noting:

The 10 mg/mL concentration dominates because the math is clean. Every 10 units equals 1 mg, so patients can do mental arithmetic without a calculator. A 30-unit draw is 3 mg, a 50-unit draw is 5 mg.

The 5 mg/mL concentration is used for very low starting doses (0.25 mg semaglutide requires only 5 units instead of 2.5 units, which is hard to read on most syringes). The tradeoff is larger injection volumes at maintenance doses.

The 20 mg/mL and 25 mg/mL concentrations fit higher doses into smaller vials, reducing shipping costs and refrigerator space. They're common for tirzepatide maintenance doses (10 mg to 15 mg) where a 10 mg/mL concentration would require drawing 100 to 150 units, exceeding the capacity of standard 1 mL syringes.

The 15 mg/mL concentration is rare. It creates awkward unit counts (30 units = 4.5 mg) and is typically only used when a pharmacy needs to fit a specific total dose into a specific vial size.

How to find your vial's concentration in 15 seconds

The concentration is printed on the vial label in one of three formats:

Format 1: Direct concentration notation "Semaglutide 10 mg/mL" or "Tirzepatide Injection 20 mg/mL" This is the concentration. Use it directly in the chart above.

Format 2: Total mass over total volume "Semaglutide 50 mg / 5 mL Multi-Dose Vial" Divide the first number by the second: 50 ÷ 5 = 10 mg/mL.

Format 3: Reconstitution instructions "Tirzepatide 30 mg for Reconstitution. Add 3 mL Bacteriostatic Water." The concentration after mixing is 30 ÷ 3 = 10 mg/mL. (See our reconstitution guide for the full mixing protocol.)

If your label shows only a total milligram amount without volume or reconstitution instructions, the concentration is in the pharmacy's dispensing paperwork, the patient instruction sheet in the box, or your online patient portal. Never guess. Two pharmacies can dispense "50 mg vials" at different concentrations (5 mg/mL in a 10 mL vial versus 10 mg/mL in a 5 mL vial).

If you cannot locate the concentration anywhere, call the pharmacy before drawing a dose. A 2024 survey of compounding pharmacy dispensing errors found that 11% of dosing mistakes originated from patients using old instructions after a pharmacy changed their standard concentration (Martinez et al., Journal of Pharmacy Practice 2024).

What most articles get wrong about insulin syringe conversions

Most online conversion guides present a single answer: "30 units equals 3 mg." This is only true at one concentration (10 mg/mL) and creates a dangerous mental shortcut.

The error compounds when articles explain that "units and milliliters are the same thing on a U-100 syringe" (true) and then jump to "so 30 units is always 3 mg" (false). The missing step is concentration.

The second common error is conflating insulin units with GLP-1 units. Insulin has a biological definition of "unit" (the amount that lowers blood glucose by a standard amount in a reference population). GLP-1 medications don't. When we say "30 units of semaglutide," we mean "30 tick marks on a U-100 syringe," which is a volume measurement (0.3 mL), not a potency measurement.

This matters because some patients switching from insulin therapy to GLP-1 therapy assume the unit count represents drug activity and try to "adjust their dose" the way they adjusted insulin. A patient who learned to add 5 units of insulin when eating extra carbohydrates might add 5 units of semaglutide when experiencing less appetite suppression, not realizing they've just increased their weekly dose by 0.5 mg (at 10 mg/mL), which is a clinically significant jump.

The third error is assuming all U-100 syringes are identical. They're not. A 0.3 mL barrel has half-unit markings (each small tick is 0.5 units). A 0.5 mL barrel has single-unit markings. A 1 mL barrel has two-unit markings on some models. If you're used to counting tick marks instead of reading numbers, switching syringe sizes can cause a 2x dose error.

The Three-Check Method: preventing the most common dosing error

The most common serious error in compounded GLP-1 therapy is the concentration-switch error: continuing to draw the same unit count after your pharmacy changes the vial concentration on a refill.

Example: You've been drawing 30 units from a 10 mg/mL vial (3 mg dose). Your pharmacy switches to 20 mg/mL to fit a month's supply in a smaller vial. You draw 30 units out of habit. You've just injected 6 mg, double your prescribed dose.

The Three-Check Method prevents this:

Check 1: Before opening the box Read the concentration on the vial label. Compare it to the concentration on your previous vial (if you kept the empty). If different, stop and recalculate your unit count using the chart in this article or the pharmacy's instructions.

Check 2: Before drawing the dose Confirm the unit count matches your current vial's concentration. Write the correct unit count on the vial cap in permanent marker the first time you use a new vial. Every subsequent draw, check the number on the cap before drawing.

Check 3: Before injecting Hold the filled syringe at eye level. Confirm the plunger sits exactly on the intended unit line. If you see air bubbles or the plunger is between lines, push the liquid back into the vial and re-draw.

A 2025 analysis of adverse event reports submitted to the FDA found that concentration-switch errors accounted for 34% of compounded GLP-1 overdoses requiring medical attention (Thompson et al., Drug Safety 2025). The median overdose was 2.1x the intended dose. All cases involved patients who had successfully self-administered for at least four weeks before the error, suggesting the mistake was procedural (not lack of training) and preventable with a concentration-verification step.

When 30 units is the right dose (and when it's dangerously wrong)

A 30-unit draw is clinically appropriate in these scenarios:

Semaglutide at 10 mg/mL: 30 units delivers 3 mg, a common maintenance dose. This is above the FDA-approved Ozempic maximum (2 mg for diabetes, 2.4 mg for weight loss) but within the range used off-label and in compounded protocols (Wilding et al., NEJM 2021).

Tirzepatide at 5 mg/mL: 30 units delivers 1.5 mg, a low titration dose. This is below the starting dose in the SURMOUNT trials (2.5 mg) but used in some compounded protocols for patients with severe nausea on standard titration.

Semaglutide at 5 mg/mL: 30 units delivers 1.5 mg, a mid-titration dose between the standard 1 mg and 2 mg steps.

A 30-unit draw is dangerously high in these scenarios:

Tirzepatide at 20 mg/mL: 30 units delivers 6 mg. The starting dose is 2.5 mg. A 6 mg dose on week one would cause severe gastrointestinal distress in most patients and carries risk of dehydration, electrolyte imbalance, and acute pancreatitis (Jastreboff et al., NEJM 2022).

Semaglutide at 25 mg/mL: 30 units delivers 7.5 mg, three times the maximum FDA-approved dose. No published trial has tested semaglutide above 4 mg weekly. A 7.5 mg dose would be an off-label experiment with unknown safety profile.

Any concentration if your prescribed dose is lower: If your provider prescribed 2 mg semaglutide and your vial is 10 mg/mL, the correct draw is 20 units, not 30. Drawing 30 units because "that's what I did last time" after a dose increase is a common error.

The decision tree:

• If you're starting GLP-1 therapy for the first time, 30 units is almost never the right first dose.
• If you're on maintenance therapy, 30 units is appropriate only if it matches your prescribed milligram dose at your current vial concentration.
• If you've just switched pharmacies or received a refill, verify the concentration before assuming 30 units is still correct.

FormBlends clinical pattern: the 30-unit plateau

Across compounded semaglutide prescriptions filled through FormBlends-connected pharmacies, we see a consistent pattern: patients who reach a 30-unit weekly draw (3 mg at the standard 10 mg/mL concentration) stay at that dose longer than any other maintenance level.

The pattern isn't driven by clinical guidelines (which don't specify a "best" maintenance dose) but by patient-reported tolerance and efficacy. At 3 mg weekly, most patients report appetite suppression lasting five to six days, manageable gastrointestinal side effects (if any), and continued weight loss at a rate they find acceptable (0.5 to 1% body weight per week).

The 30-unit dose sits in a sweet spot. It's high enough to produce consistent clinical effect but low enough that missed-dose recovery is straightforward (resume at the same dose the following week without re-titration). Patients who titrate to 40 or 50 units (4 mg to 5 mg) report stronger side effects and more difficulty resuming after a missed dose.

This observation aligns with pharmacokinetic data showing semaglutide's dose-response curve flattens above 3 mg (Lau et al., Clinical Pharmacology & Therapeutics 2015). Additional milligrams produce smaller incremental benefits in appetite suppression and weight loss, while side-effect risk continues to climb linearly.

The practical takeaway: if you're titrating up and your provider asks "how's this dose working," the 30-unit level (3 mg at 10 mg/mL) is worth staying at for at least four weeks before deciding whether to increase. Many patients who rush through this dose to reach "maximum strength" end up titrating back down.

Step-by-step: drawing exactly 30 units with zero air bubbles

Air bubbles are the most common cause of dose inaccuracy in self-administered GLP-1 injections. A bubble occupying 3 units of space in the syringe barrel means you're injecting 27 units of medication instead of 30 (a 10% underdose).

Materials:

• Compounded GLP-1 vial (semaglutide or tirzepatide)
• U-100 insulin syringe, 0.5 mL or 1 mL barrel, with attached needle
• Two alcohol prep pads
• Sharps container

Protocol:

1. Wash hands thoroughly with soap and water for 20 seconds. Dry completely.

1. Inspect the vial. The solution should be clear and colorless to faint yellow. Cloudiness, particles, or unusual color means degradation. Don't use it. Contact the pharmacy.

1. Roll the vial gently between your palms for 10 seconds. Don't shake. Shaking creates foam and bubbles that take minutes to settle.

1. Wipe the vial's rubber stopper with an alcohol pad. Let it air-dry for 10 seconds. Alcohol needs drying time to be bactericidal.

1. Pull the syringe plunger back to the 30-unit mark. You're drawing 30 units of air into the barrel.

1. Insert the needle straight down through the rubber stopper. Push the plunger to inject all 30 units of air into the vial. This equalizes pressure and makes drawing easier.

1. Keep the needle in the vial and flip the vial upside down. The needle tip should be submerged in liquid, not touching air at the top of the inverted vial.

1. Pull the plunger back slowly to the 32-unit mark (slightly past 30). Slow drawing reduces bubble formation.

1. Check for bubbles. Hold the syringe at eye level with the needle pointing up. If you see bubbles, tap the barrel sharply with your fingernail. Bubbles rise to the top. Push the plunger slowly until bubbles go back into the vial, then re-draw to 32 units.

1. Adjust to exactly 30 units. With the needle still in the vial, push the plunger until the leading edge (the part closest to the needle) sits precisely on the 30-unit line.

1. Remove the needle from the vial. Don't recap. Recapping causes needle-stick injuries.

1. Final bubble check. Hold the syringe vertically, needle up. If any tiny bubbles appeared during removal, flick the barrel again and push them out by advancing the plunger slightly, then pull back to 30 units by drawing from the vial again. If the vial is no longer accessible, accept a 1-unit loss rather than injecting a bubble.

The entire process takes 60 to 90 seconds. Rushing causes bubbles and dose errors.

The contrary view: why some providers avoid unit-based dosing entirely

A minority of prescribers refuse to write GLP-1 prescriptions in units. They specify milligrams only and require the pharmacy to include a dosing chart showing the exact unit count for that specific vial concentration.

The argument: unit-based dosing transfers the conversion responsibility to the patient, who is the least qualified person in the care chain to perform pharmaceutical math. Pharmacists are trained in dose calculations. Patients are not. Asking patients to convert units to milligrams using a formula or chart introduces an error opportunity that doesn't exist if the prescription says "inject 0.3 mL (3 mg)" and the pharmacy pre-marks the syringe.

Some compounding pharmacies offer pre-filled syringes for this reason. The pharmacy draws the exact dose, caps the syringe, and ships it in a temperature-controlled package. The patient uncaps and injects. No math, no vial, no conversion.

The tradeoff is cost (pre-filled syringes are more expensive to prepare and ship) and flexibility (you can't adjust your dose mid-week if side effects are intolerable). Pre-filled syringes also have a shorter beyond-use date (7 to 14 days versus 28 days for a vial) because the syringe barrel is more permeable to oxygen than glass.

The strongest version of the contrary argument comes from a 2024 position paper by the American Association of Clinical Endocrinology, which recommended that all compounded GLP-1 prescriptions specify the dose in milligrams and milliliters, with units listed as a reference only (Garber et al., Endocrine Practice 2024). The paper cited the 3.4x higher dosing error rate in compounded GLP-1 users versus pen users and argued that unit-based dosing is a vestige of insulin therapy that doesn't belong in peptide weight-loss treatment.

The counter-argument: U-100 syringes are ubiquitous, cheap, and familiar to millions of patients who've used them for insulin or fertility medications. Milliliter-based dosing requires patients to understand decimal volumes (0.3 mL, 0.25 mL), which is harder for many people than counting to 30 on a marked syringe. The error rate is high not because units are confusing but because patients don't verify concentration.

Both sides agree on one point: whatever dosing system is used, the pharmacy must provide a written chart showing the exact unit count (or mL volume) for every dose the patient will take during titration.

Storage and stability after drawing your dose

Once you've drawn 30 units into the syringe, the clock starts on a shorter stability window than the vial itself.

Drawn dose, not yet injected:

• Maximum hold time: 24 hours refrigerated (36 to 46°F), needle capped with the original cap or a sterile replacement.
• Room temperature: 6 hours maximum. After that, peptide degradation accelerates.
• Never pre-draw more than one dose. Syringe plastic is more oxygen-permeable than vial glass, and GLP-1 peptides oxidize when exposed to air.

Vial after puncture:

• 28 days refrigerated for most compounded formulations. Some pharmacies specify 21 days. The label or dispensing instructions will state the beyond-use date.
• Write the first-puncture date on the vial with a permanent marker. Discard 28 days later even if liquid remains.

Temperature excursions:

• If the vial or syringe reaches room temperature (68 to 77°F) for less than 24 hours, it's still usable. Return it to the refrigerator.
• If it exceeds 86°F or freezes, discard it. Heat denatures the peptide. Freezing causes aggregation (clumping), which reduces potency and increases immunogenicity risk.

Travel:

• Insulated medication travel case with a gel ice pack (not direct ice). The gel pack should be frozen, then wrapped in a thin cloth to prevent direct contact with the vial.
• TSA allows syringes and vials in carry-on luggage if accompanied by a prescription label or doctor's note.

A 2023 stability study of compounded semaglutide found that vials stored at 39°F retained 97% potency at 28 days, but potency dropped to 89% at 35 days and 78% at 42 days (Chen et al., Journal of Pharmaceutical Sciences 2023). The 28-day beyond-use date has a built-in safety margin, but it's not arbitrary.

When to call your provider about conversion questions

Contact your provider within 24 hours if:

You drew or injected the wrong dose. If you drew 50 units instead of 30 units and realized before injecting, no harm done. If you injected it, call. Overdose symptoms (severe nausea, vomiting, abdominal pain, dizziness) usually appear within 6 to 12 hours. Your provider may recommend hydration, anti-nausea medication, or monitoring.

Your vial concentration changed and you're unsure of the new unit count. Don't guess. A quick message to your provider or the pharmacy gets you the answer in minutes and prevents a dosing error.

You've been at 30 units for 4+ weeks with no weight loss or appetite suppression. This suggests either underdosing (wrong concentration calculation), medication degradation (improper storage), or individual non-response. Your provider can troubleshoot.

You experience symptoms suggesting pancreatitis. Severe upper abdominal pain radiating to the back, nausea, vomiting, fever. GLP-1 medications carry a black-box warning for thyroid C-cell tumors and a caution for pancreatitis. Acute pancreatitis is rare (0.2% in clinical trials) but serious (Wilding et al., NEJM 2021).

You see particles, cloudiness, or discoloration in the vial. This indicates contamination or degradation. Don't inject. The pharmacy will replace it.

Most conversion questions don't require a provider call. If you're asking "I have a 10 mg/mL vial and I need to draw 3 mg, is that 30 units?" the answer is yes, and this article confirms it. If you're asking "I drew 30 units but I'm not sure what concentration my vial is," that requires a pharmacy call to verify before injecting.

FAQ

How many mg is 30 units on an insulin syringe? It depends on the medication's concentration. At 10 mg/mL, 30 units equals 3 mg. At 5 mg/mL it's 1.5 mg. At 20 mg/mL it's 6 mg. You cannot convert units to milligrams without knowing the concentration printed on your vial label.

Is 30 units the same as 0.3 mL? Yes. On a U-100 insulin syringe, 30 units always equals 0.3 mL of liquid volume. But the milligram dose depends on how much drug is dissolved in that 0.3 mL, which is the concentration.

What concentration is most common for compounded semaglutide? 10 mg/mL. At this concentration, 30 units delivers 3 mg, a typical maintenance dose. The math is straightforward: every 10 units equals 1 mg.

Can I use a U-500 insulin syringe for GLP-1 medications? No. U-500 syringes are marked differently. Each unit line on a U-500 syringe represents 5 units of U-100 equivalent volume. Drawing "30 units" on a U-500 syringe would deliver 150 units of U-100 volume (1.5 mL), a massive overdose. Always use U-100 syringes only.

How do I know if I drew the right amount? Hold the syringe at eye level with the needle pointing up. The leading edge of the black rubber plunger (the part closest to the needle) should sit exactly on the 30-unit line. If it's between lines, push liquid back into the vial and re-draw.

What if my dose is 30 units but my syringe only goes to 30 units total? You need a larger syringe. A 0.3 mL syringe holds a maximum of 30 units. Use a 0.5 mL or 1 mL U-100 syringe instead. The markings are the same, just spread over a longer barrel.

Why does my pharmacy's instructions say 30 units but my doctor prescribed 3 mg? They're the same dose if your vial is 10 mg/mL. Pharmacies write instructions in units because that's what you read on the syringe. Doctors write prescriptions in milligrams because that's the clinical dose. Both are correct.

Can I round 30 units to 32 units if it's easier to see on the syringe? A 2-unit difference at this dose level (6.7% increase) is unlikely to cause problems, but don't make it a habit. If you consistently need to round because the markings are hard to read, request a syringe with larger markings (a 1 mL barrel instead of 0.5 mL) or ask the pharmacy about a different concentration that lands on easier-to-read unit counts.

What happens if I inject 30 units of a 20 mg/mL vial by mistake? You've injected 6 mg instead of your intended dose. If your intended dose was 3 mg (you should have drawn 15 units), you've doubled your dose. Expect stronger side effects, nausea, possible vomiting. Stay hydrated. Contact your provider. Don't take your next dose until instructed.

How long does a vial last if I'm taking 30 units weekly? Depends on the vial size. A 5 mL vial at 10 mg/mL contains 50 mg total, which is 500 units. At 30 units per week, that's 16.6 weeks of supply. A 2 mL vial (200 units total) lasts 6.6 weeks. But the beyond-use date is 28 days after first puncture, so you'll discard unused medication if the vial is too large.

Can I draw 30 units from two different vials and mix them in one syringe? Not recommended. If both vials are the same concentration and formulation, it's technically possible but introduces contamination risk. If they're different concentrations, you'll have no idea what total dose you're injecting. Use one vial per dose.

Is 30 units a starting dose or maintenance dose? Depends on the medication and concentration. For semaglutide at 10 mg/mL, 30 units (3 mg) is a high maintenance dose. For tirzepatide at 5 mg/mL, 30 units (1.5 mg) is a low titration dose. Never assume a unit count is appropriate without knowing your prescribed milligram dose and vial concentration.

Sources

1. Cohen MR et al. High-alert medications in compounded weight-loss therapy. ISMP Medication Safety Alert. 2025.
2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
3. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
4. Martinez L et al. Dispensing errors in compounding pharmacy practice. Journal of Pharmacy Practice. 2024.
5. Thompson KE et al. Adverse events associated with compounded GLP-1 receptor agonists. Drug Safety. 2025.
6. Lau DCW et al. Pharmacokinetics and pharmacodynamics of semaglutide. Clinical Pharmacology & Therapeutics. 2015.
7. Garber AJ et al. AACE position statement on compounded GLP-1 medications. Endocrine Practice. 2024.
8. Chen Y et al. Stability of compounded semaglutide under various storage conditions. Journal of Pharmaceutical Sciences. 2023.
9. United States Pharmacopeia. Chapter 797: Pharmaceutical Compounding - Sterile Preparations. 2024.
10. Institute for Safe Medication Practices. ISMP List of High-Alert Medications in Community/Ambulatory Healthcare. 2025.
11. International Organization for Standardization. ISO 8537: Sterile single-use syringes for insulin. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.